Evidence map›Paper›PMID 41869672›Full record

ArticleFrontiers in oncology2026

Case Report:

Fabiano Flauto, Filippo Vitale, Caterina De Luca, Rosa Maria Di Crescenzo, Francesco Petteruti, Annarita Peddio, Giuseppe Neola, Vincenzo Damiano

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fabiano Flauto *Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Filippo Vitale *Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Caterina De LucaDepartment of Public Health, University of Naples Federico II, Naples, Italy.
Rosa Maria Di CrescenzoDepartment of Advanced Biomedical Sciences, University of Naples, Naples, Italy.
Francesco PetterutiU.O. Thoracic Surgery Pineta Grande Hospital, Castelvolturno, CE, Italy.
Annarita PeddioDepartment of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Giuseppe NeolaDepartment of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Vincenzo DamianoDepartment of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Inflammatory myofibroblastic tumour (IMT) is a rare mesenchymal neoplasm, frequently driven by oncogenic kinase fusions, most commonly involving anaplastic lymphoma kinase ( Case presentation: We report the case of a young adult woman with an Conclusion: This case highlights the importance of comprehensive molecular testing in IMT to identify actionable

Indexed as

ALK-fusioncase reportinflammatory myofibroblastic tumourlorlatinibTPR-ALK

Identifiers

PMID41869672
PMCPMC12999375

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.